Hydroceramide as a novel Biomarker of Premature Atherosclerosis

31 August 2025 (08:15 - 09:00)

Organised by:

Video

Sign in for access options

Abstract

Slides

About the speaker

Associate Professor Michel Zeitouni

Pitie Salpetriere APHP University Hospital, Paris (France)

6 More presentations in this session

Presentation thumbnail

Serum low-density lipoprotein cholesterol levels are correlated with markers of neutrophil activation in patients with coronary atherosclerosis

Ms A. Ondracek (Vienna, AT)

Abstract Slides Video

Presentation thumbnail

Persistently increased NT-pro BNP one year after acute coronary syndrome: insights from the SPUM-ACS registry

Doctor F. Wenzl (Zurich, CH)

Abstract Slides Video

Presentation thumbnail

Comparative assessment of inflammatory biomarker levels across subtypes of Myocardial Infarction with Non-Obstructive Coronary Arteries. A pilot study

Doctor M. Espinosa Pascual (Madrid, ES)

Abstract Slides Video

Presentation thumbnail

Oxidized low-density lipoprotein cholesterol and plaque vulnerability in patients with diabetes mellitus

Doctor J. Goto (Yamagata, JP)

Abstract Slides Video

Presentation thumbnail

Early blood-derived predictors of final infarct size in patients with anterior STEMI and primary PCI

Miss S. Wallis (Newcastle Upon Tyne, GB)

Abstract Slides Video

Access the full session

Session thumbnail

Biomarkers in acute coronary syndromes (4)

The Event

Event poster

ESC Congress 2025

31 August 2025 08:15 CET

You may be interested in

Congress Presentation

Which biomarkers are useful to risk stratify in primary prevention?

Congress Presentation

Ceramides surpass LDL-cholesterol in predicting cardiovascular mortality in patients with as well as in patients without the metabolic syndrome

Congress Session

Novel biomarkers for cardiovascular risk assessment

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources